345 EAST MAIN STREET, WARSAW, IN
Increases Share Repurchase Expectations — Up to $1 Billion by Year End
Announces Chief Financial Officer Transition
Announces First Quarter 2026 Financial Results
Annual Report to Security Holders
Announces Fourth Quarter and Full-Year 2025 Financial Results
Mark Bezjak Resigns from Zimmer Biomet Holdings, Effective January 16, 2026
Announces Third Quarter 2025 Financial Results
Completes Acquisition of Monogram Technologies
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Certificate
Registration of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Definitive Additional Information Statement
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Free Writing Prospectus